Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Nystatin 100,000units/ml oral suspension |
| BNF code | 0502030B0AAABAB |
| Virtual Therapeutic Moiety | Nystatin |
| Date identifier became valid | 12 May 2023 |
| Previous product identifier | 324689003 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 14 Feb 2003 |
| Previous name | Nystatin 100,000 units/ml oral suspension |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Nystatin |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 100000.000 |
| Strength value numerator unit | unit |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Nystatin 100,000units/ml oral suspension (A A H Pharmaceuticals Ltd) | |
| Nystatin 100,000units/ml oral suspension (Alliance Healthcare (Distribution) Ltd) | |
| Nystatin 100,000units/ml oral suspension (Sigma Pharmaceuticals Plc) | |
| Nystatin 100,000units/ml oral suspension (Zydus Pharmaceuticals UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Nystatin 100,000units/ml oral suspension 30 ml | |
dm+d data retrieved from TRUD: release NHSBSA_10.3.0_20251027000001, imported on 28th October 2025 at 04:07:32.